AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
A RANDOMIZED STUDY TO EVALUATE THE EFFECT OF HYDRALAZINE ON THE DEVELOPMENT OF NITRATE TOLERANCE IN PATIENTS WITH HEART-FAILURE
Authors: GODJA H MEHRA A PARIKH S AJITUPPAL J JOHNSON JV ELKAYAM U
Citation: H. Godja et al., A RANDOMIZED STUDY TO EVALUATE THE EFFECT OF HYDRALAZINE ON THE DEVELOPMENT OF NITRATE TOLERANCE IN PATIENTS WITH HEART-FAILURE, Circulation, 90(4), 1994, pp. 601-601
POTENTIATION OF ISOSORBIDE DINITRATE EFFECTS WITH N-ACETYLCYSTEINE INPATIENTS WITH CHRONIC HEART-FAILURE
Authors: MEHRA A SHOTAN A OSTRZEGA E HSUEH W VASQUEZJOHNSON J ELKAYAM U
Citation: A. Mehra et al., POTENTIATION OF ISOSORBIDE DINITRATE EFFECTS WITH N-ACETYLCYSTEINE INPATIENTS WITH CHRONIC HEART-FAILURE, Circulation, 89(6), 1994, pp. 2595-2600
RISKS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION DURING PREGNANCY - EXPERIMENTAL AND CLINICAL-EVIDENCE, POTENTIAL MECHANISMS, AND RECOMMENDATIONS FOR USE
Authors: SHOTAN A WIDERHORN J HURST A ELKAYAM U
Citation: A. Shotan et al., RISKS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION DURING PREGNANCY - EXPERIMENTAL AND CLINICAL-EVIDENCE, POTENTIAL MECHANISMS, AND RECOMMENDATIONS FOR USE, The American journal of medicine, 96(5), 1994, pp. 451-456
CALCIUM-CHANNEL BLOCKERS IN HEART-FAILURE
Authors: ELKAYAM U SHOTAN A MEHRA A OSTRZEGA E
Citation: U. Elkayam et al., CALCIUM-CHANNEL BLOCKERS IN HEART-FAILURE, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000139-10000144
MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .3. NEW APPROACHES TO THE TREATMENT OF HEART-FAILURE - DISCUSSION-VI
Authors: PACKER M CODY RJ COHN JN ELKAYAM U SOLE MJ THAMES MD
Citation: M. Packer et al., MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .3. NEW APPROACHES TO THE TREATMENT OF HEART-FAILURE - DISCUSSION-VI, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000145-10000145
MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .3. NEW APPROACHES TO THE TREATMENT OF HEART-FAILURE - DISCUSSION-VII
Authors: PACKER M BENEDICT CR CODY RJ COHN JN ELKAYAM U GUYATT GH KATZ AM PFEFFER MA PITT B SONNENBLICK EH YUSUF S
Citation: M. Packer et al., MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .3. NEW APPROACHES TO THE TREATMENT OF HEART-FAILURE - DISCUSSION-VII, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000162-10000164
MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .4. ASSESSMENT OF CLINICAL OUTCOME IN HEART-FAILURE - DISCUSSION-IX
Authors: PITT B ELKAYAM U GUYATT GH LIPICKY RJ PACKER M YUSUF S
Citation: B. Pitt et al., MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .4. ASSESSMENT OF CLINICAL OUTCOME IN HEART-FAILURE - DISCUSSION-IX, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000192-10000193
DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY OF FLOSEQUINANIN PATIENTS WITH CHRONIC HEART-FAILURE
Authors: PACKER M NARAHARA KA ELKAYAM U SULLIVAN JM PEARLE DL MASSIE BM CREAGER MA
Citation: M. Packer et al., DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY OF FLOSEQUINANIN PATIENTS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 22(1), 1993, pp. 65-72
PLASMA CYCLIC GUANOSINE-MONOPHOSPHATE IN CHRONIC HEART-FAILURE - HEMODYNAMIC AND NEUROHORMONAL CORRELATIONS AND RESPONSE TO NITRATE THERAPY
Authors: SHOTAN A MEHRA A OSTRZEGA E HSUEH W DO YS FISHER DA HURST A JOHNSON JV ELKAYAM U
Citation: A. Shotan et al., PLASMA CYCLIC GUANOSINE-MONOPHOSPHATE IN CHRONIC HEART-FAILURE - HEMODYNAMIC AND NEUROHORMONAL CORRELATIONS AND RESPONSE TO NITRATE THERAPY, Clinical pharmacology and therapeutics, 54(6), 1993, pp. 638-644
CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET)
Authors: MASSIE BM BERK MR BROZENA SC ELKAYAM U PLEHN JF KUKIN ML PACKER M MURPHY BE NEUBERG GW STEINGART RM LEVINE TB DEHAAN H
Citation: Bm. Massie et al., CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET), Circulation, 88(2), 1993, pp. 492-501
Risultati: 1-25 | 26-35 |